Share film

The technology is advancing, this phenomenon is particularly prominent in the development process of the smart phone.To share with you today, higher technology content of cell phone technology.

NTT Docomo have developed a prototype smartphone that works through touch on the front and back, using touchpanels on both sides of a see-through display.This smartphone is being co-developed by Docomo and Fujitsu. By using it from the back, you can scroll the screen without obscuring the display, and reach the slide down notification bar easily with your index finger. Docomo also implemented a new way of using smartphones or moviles baratos, by touching both sides at once."You could hold down an icon on the front, and slide on the back to move an icon, or use the message bar, or create a new application. For example, from the front, you can only move the whole Rubik cube like this, but if you slide your finger across the front while holding down the back, you can rotate just one face. So this display makes gripping operations possible.""The display is QVGA (320 x 240), at 2.4 inches. We think it needs to be bigger if we're to market this kind of phone. But even in this form, we think it could be used as a sub-display. In that case, it will have a limited display capability, so we think the range of applications could be wider.""Compared with a standard smartphone libres, this one still has slightly low brightness, so it's a bit hard to view in bright places. We'd like to improve the technology to overcome things like that."

This is a representative works for the development of the screen,the following is a cell phone camera in the medical application.

Khosla Ventures, the investment firm headed up by noted venture capitalist and Sun Microsystems co-founder Vinod Khosla, is increasingly making investments in mobile health startups. Khosla Ventures has made three investments in mobile health companies in as many months. In April we noted that Khosla had contributed to Misfit Wearables’ $7.6 million second round of funding and just this morning we reported on Khosla leading the $10.5 million second round of funding for AliveCor.

Khosla Ventures also recently invested $1 million in CellScope, an alum from Rock Health’s first class of startups in 2011. The company is developing smartphone peripheral devices designed for consumers to use for at-home diagnosis.

Think of it as a “modern-day digital first aid kit.”

CellScope’s first offering will be a smartphone-enabled otoscope that will enable physicians to remotely diagnose ear infections in children. Parents will be able to use the peripheral, which attaches to a teléfonos baratos camera lens, to send an image of their child’s inner ear that physicians can use to make a diagnosis and then write a prescription if need be. CellScope says ear infections in children make up 30 million doctor visits annually in the US alone. The consumer device would help parents miss less work and potentially cut down on late night emergency room visits, according to the startup.

The startup traces its origins to bioengineering Professor Dan Fletcher’s lab at UC Berkeley, where CellScope founders Erik Douglas and Amy Sheng were developingteléfonos moviles baratos(free cellphone)-microscopy for remote diagnosis in developing countries. CellScope expects to launch future products focused on throat and skin exams, including non-clinical apps for consumer skincare.

Here’s how Fletcher, who has also advised the Obama Administration on science and technology in the past, described his work on CellScope, according to a MobiHealthNews report in mid-2009:

“A second opportunity for the government to promote mobile health is through sponsoring research and development. This, I’ll use an example from my own lab at Berkeley. The result was a simple attachment to a cell phone [called CellScope] that would allow you to take images of sputum samples or blood samples. We designed this and decided try and build it. It seems to give us reasonable results. This is an example of a blood smear on that phone and this is a sickle cell sample. Being able to do sickle cell screening in the field both abroad as well as in this country in lower resource areas has potential. Technologies in the distant future may enable use of this sort of imaging capability to take some of the back laboratory tests that need to be run and put those in the hands of patients or mobile health workers.”

“Health data, the key ingredient to useful analysis and diagnosis, is starting to explode exponentially – and CellScope is on the cutting edge,” Vinod Khosla said in a written statement. “Erik and his team are creating next-generation technology that will empower patients and help them access the best care in the most efficient manner possible.”

The power of technology is great, the technology of human life more convenient.